Complexo Hospitalario Universitario de Vigo
Centro de atención
Antoni
Castells
Publicacións nas que colabora con Antoni Castells (41)
2020
-
Validation of miR-1228-3p as housekeeping for microRNA analysis in liquid biopsies from colorectal cancer patients
Biomolecules, Vol. 10, Núm. 1
2019
-
Correction: Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer (Clinical and Translational Gastroenterology, (2019) 10, e-00031, 10.14309/ctg.0000000000000003)
Clinical and Translational Gastroenterology
-
High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome
Endoscopy, Vol. 51, Núm. 2, pp. 142-151
2018
-
Plasma miRNAs signature validation for early detection of colorectal cancer
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. v106
2017
-
Candidate predisposing germline copy number variants in early onset colorectal cancer patients
Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 625-632
-
Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs
United European Gastroenterology Journal, Vol. 5, Núm. 2, pp. 255-260
2016
-
Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC)
Carcinogenesis, Vol. 37, Núm. 8, pp. 751-758
-
Colorectal cancer risk factors in patients with serrated polyposis syndrome: A large multicentre study
Gut, Vol. 65, Núm. 11, pp. 1829-1837
-
Endoscopist characteristics that influence the quality of colonoscopy
Endoscopy, Vol. 48, Núm. 3, pp. 241-247
-
Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening
Digestive and Liver Disease, Vol. 48, Núm. 5, pp. 542-551
-
Incidence of advanced neoplasia during surveillance in high- and intermediate-risk groups of the European colorectal cancer screening guidelines
Endoscopy, Vol. 48, Núm. 11, pp. 995-1002
2015
-
Diagnostic Performance of Fecal Immunochemical Test and Sigmoidoscopy for Advanced Right-Sided Colorectal Neoplasms
Digestive Diseases and Sciences, Vol. 60, Núm. 5, pp. 1424-1432
-
Prevalence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer
Journal of Medical Genetics, Vol. 52, Núm. 7, pp. 498-502
2014
-
A genome-wide association study on copy-number variation identifies a 11q11 loss as a candidate susceptibility variant for colorectal cancer
Human Genetics, Vol. 133, Núm. 5, pp. 525-534
-
Effect of oral anticoagulants on the outcome of faecal immunochemical test
British Journal of Cancer, Vol. 110, Núm. 5, pp. 1334-1337
-
High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families
Clinical Genetics, Vol. 85, Núm. 6, pp. 583-588
-
Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening
Cancer Causes and Control, Vol. 25, Núm. 8, pp. 985-997
-
Rate of Detection of Advanced Neoplasms in Proximal Colon by Simulated Sigmoidoscopy vs Fecal Immunochemical Tests
Clinical Gastroenterology and Hepatology, Vol. 12, Núm. 10, pp. 1708-1716.e4
2013
-
A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12
BMC Genomics, Vol. 14, Núm. 1
-
BMP2/BMP4 colorectal cancer susceptibility loci in northern and southern european populations
Carcinogenesis, Vol. 34, Núm. 2, pp. 314-318